samedan logo
 
 
spacer
home > epc > Spring 2017
PUBLICATIONS

European Pharmaceutical Contractor

epc
Spring 2017

   
Text
PDF
bullet
Data Management & IT Solutions
Spotlight

Transforming Software


Bracket’s Steve Rawbone and Stephane Deleger highlight the advantages of iterative design and user acceptance testing, detailing how this can reduce the complexity of clinical trials.
 
view
download pdf
bullet
DATA MANAGEMENT
Electronic Data Interchange

Destination: Automation


A hands-off approach to trials, through to the automation of processes such as the managing of inventories, is a new industry goal, but Ian Davison at HMD Clinical suggests that this raises its own questions.
 
view
download pdf
bullet
Supply Chain Management
Supply Management
 
Getting Interactive


Utilisation of intelligent IRT systems is the best way to meet the demands of clinical supply management, argues Stefan Dürr at Cenduit, as this can save time and eliminate unnecessary work.
 
view
download pdf
Local Trial Supply

The Hungarian Way


Many countries in the CEE region are now looking to local companies for several supply activities, so Tibor Kovacs at PharmaRoad expands on the reasons why Hungary is leading this trend.
 
view
download pdf
Managing Risk

Risky Business


Nils Markmann at World Courier explains how manufacturers can prepare for growing challenges in the modern mobile supply chain, protecting both themselves and patients.
 
view
download pdf
   
spacer



Published quarterly in
February, May,
August, and November

News and Press Releases

Clinical and Regulatory Operational Excellence Forum

1. Innovative technologies are expected to take clinical development, licensing, and other regulatory processes to the next level in the future. What do you see are the biggest challenges facing companies when trying to cope with continued data growth in a fast changing environment? Pharmaceutical companies are heavily regulated and introducing change needs proof of acceptance by the authorities. The chance that authorities do not agree with that change makes the industry risk averse. Changes in a stable GxP environment are almost by default seen as a risk, however, not adapting to new technologies should also be seen as a risk! Therefore, ICH developed the ICH Q8, Q9, Q10, Q11, and Q12 guidelines, to anticipate change and implement changes much faster, with less of a regulatory burden. Nevertheless, industry is not picking up with the desired pace. Why not?
More info >>

White Papers

Wrap Around Label - A Lot of Content in a Small Space

Faubel & Co. Nachfolger GmbH

One of the world’s largest contract research organizations for the planning and conducting of clinical trials was faced with the challenge of accommodating many different national languages on an inhaler. The inhaler was then to be distributed in 47 countries. Due to the impressive quality and reliable collaboration, the organization commissioned Faubel with finding the optimal labeling solution for the inhaler.
More info >>

Industry Events

Pharma Packaging and Labelling East Coast 2019

20-21 February 2019, Phildaelphia, USA

Now in its 11th year, Pharma Packaging and Labeling is back to deliver key, actionable insights into very latest regulatory requirements, technological innovations, strategic developments, and how to implement them into your packaging and labeling chain with both maximum efficiency and minimal cost.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement